Skip to main content Accessibility help
  • Print publication year: 2014
  • Online publication date: April 2014

Chapter 1 - Phenomenology, classification, and diagnostic approach to patients with movement disorders

from Section I - General principles
    • By Marjolein B. Aerts, Department of Neurology and Parkinson Centre Nijmegen, Donders Institute for Brain Cognition & Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands, Joseph Jankovic, Baylor College of Medicine, Texas , Bart P. van de Warrenburg, Department of Neurology and Parkinson Centre Nijmegen, Donders Institute for Brain Cognition & Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands, Bastiaan R. Bloem, Department of Neurology and Parkinson Centre Nijmegen, Donders Institute for Brain Cognition & Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
  • Edited by Werner Poewe, Joseph Jankovic, Baylor College of Medicine, Texas
  • Publisher: Cambridge University Press
  • DOI:
  • pp 1-15



In this introductory chapter, we will discuss the phenomenology of movement disorders and its importance in classification and diagnostic work-up in patients presenting with one or more types of movement disorders. We will place great emphasis on the most important step in this diagnostic process, which is the clinical approach based on recognition of the phenomenologic characteristics of the movement disorder. An accurate clinical description and adequate recognition of the type of movement disorder (or multiple types, as is often the case) in turn forms the basis for a tailored set of ancillary investigations to confirm the clinical suspicion. Thanks to rapid technological advancements (for example, in the fields of genetics and functional imaging), clinicians now have a battery of advanced ancillary investigations at their disposal. In this chapter, we will discuss the rational use of some of the most commonly required tests. However, we should point out that the clinical pattern recognition remains the vital starting point for any diagnostic approach, and that many ancillary investigations offer relatively little added value over and above the diagnostic accuracy of a clinical neurological examination (Constantinescu et al. 2009; Seppi and Schocke 2005; Morris and Jankovic 2012).

Abdo, W. F., van de Warrenburg, B. P., Burn, D. J., Quinn, N. P., and Bloem, B. R. (2010). “The clinical approach to movement disorders,” Nat. Rev. Neurol. 6(1): 29–37.
Aerts, M. B., Esselink, R. A., Bloem, B. R., and Verbeek, M. M. (2011a). “Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome,” Mov. Disord. 26(1): 169–73.
Aerts, M. B., Esselink, R. A., Claassen, J. A., Abdo, W. F., Bloem, B. R., and Verbeek, M. M. (2011b). “CSF tau, Abeta42, and MHPG differentiate dementia with Lewy bodies from Alzheimer’s disease,” J. Alzheimers Dis. 27(2): 377–84.
Aerts, M. B., Esselink, R. A., Post, B., van de Warrenburg, B. P., and Bloem, B. R. (2012). “Improving the diagnostic accuracy in parkinsonism: a three-pronged approach,” Pract. Neurol. 12(2): 77–87.
Albanese, A., Bhatia, K., Bressman, S. B., Delong, M. R., Fahn, S., Fung, V. S., et al. (2013). “Phenomenology and classification of dystonia: a consensus update,” Mov. Disord. 28(7): 863–73.
Albanese, A. and Jankovic, J. (2012). Hyperkinetic Movement Disorders. (Oxford: Wiley-Blackwell).
Ashoori, A. and Jankovic, J. (2008). “Mozart’s movements and behaviour: a case of Tourette’s syndrome?,” Postgrad. Med. J. 84(992): 313–17.
Baizabal-Carvallo, J. F. and Jankovic, J. (2012). “Movement disorders in autoimmune diseases,” Mov. Disord. 27(8): 935–46.
Baizabal-Carvallo, J. F., Stocco, A., Muscal, E., and Jankovic, J. (2013). “The spectrum of movement disorders in children with anti-NMDA receptor encephalitis,” Mov. Disord. (in press).
Bhatia, K. P. (2011). “Paroxysmal dyskinesias,” Mov. Disord. 26(6): 1157–65.
Brooks, D. J. (2010). “Imaging dopamine transporters in Parkinson’s disease,” Biomark Med. 4(5): 651–60.
Cheng, E. M., Tonn, S., Swain-Eng, R., Factor, S. A., Weiner, W. J., and Bever, C. T. (2010). “Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology,” Neurology, 75(22): 2021–7.
Constantinescu, R., Zetterberg, H., Holmberg, B., and Rosengren, L. (2009). “Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders,” Parkinsonism Relat. Disord. 15(3): 205–12.
Corbett, M. A., Schwake, M., Bahlo, M., Dibbens, L. M., Lin, M., Gandolfo, L. C., et al. (2011). “A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia,” Am. J. Hum. Genet. 88(5): 657–63.
Daniel, S. E. and Lees, A. J. (1993). “Parkinson’s Disease Society Brain Bank, London: overview and research,” J. Neural Transm. Suppl. 39: 165–72.
Deuschl, G., Bain, P., and Brin, M. (1998). “Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee,” Mov. Disord. 13(3): 2–23.
Dhungana, S. and Jankovic, J. (2013). “Yips and other movement disorders in golfers,” Mov. Disord. 28: 576–81.
Dusek, P., Jankovic, J., and Le, W. (2012). “Iron dysregulation in movement disorders,” Neurobiol. Dis. 46(1): 1–18.
Edwards, M. J. and Bhatia, K. P. (2012). “Functional (psychogenic) movement disorders: merging mind and brain,” Lancet Neurol. 11(3): 250–60.
Elble, R. and Deuschl, G. (2011). “Milestones in tremor research,” Mov. Disord. 26(6): 1096–105.
Fahn, S., Jankovic, J., and Hallett, M. (2011). Principles and Practice of Movement Disorders (Philadelphia, PA: Churchill Livingstone, Elsevier), pp. 1–548.
Hallett, M., Lang, A. E., Jankovic, J., Fahn, S., Halligan, P. W., Voon, V., et al. (2011). Psychogenic Movement Disorders and Other Conversion Disorders (Cambridge University Press).
Jankovic, J. (2008). “Parkinson’s disease: clinical features and diagnosis,” J. Neurol. Neurosurg. Psychiatry 79: 368–76.
Jankovic, J. (2011). “Diagnosis and treatment of psychogenic parkinsonism,” J. Neurol. Neurosurg. Psychiatry 82(12): 1300–3.
Jankovic, J. and Kurlan, R. (2011). “Tourette syndrome: evolving concepts,” Mov. Disord. 26(6): 1149–56.
Jankovic, J., Schwartz, K. S., and Ondo, W. (1999). “Re-emergent tremor of Parkinson’s disease,” J. Neurol. Neurosurg. Psychiatry 67(5): 646–50.
Klein, C. and Ozelius, L. J. (2002). “Dystonia: clinical features, genetics, and treatment,” Curr. Opin. Neurol. 15(4): 491–7.
Köllensperger, M., Geser, F., Seppi, K., Stampfer-Kountchev, M., Sawires, M., Scherfler, C., et al. (2008). “Red flags for multiple system atrophy,” Mov. Disord. 23(8): 1093–9.
Lance, J. W. (1986). “Action myoclonus, Ramsay Hunt syndrome, and other cerebellar myoclonic syndromes,” Adv. Neurol. 43: 33–55.
Lozsadi, D. (2012). “Myoclonus: a pragmatic approach,” Pract. Neurol. 12(4): 215–24.
Mahlknecht, P., Hotter, A., Hussl, A., Esterhammer, R., Schocke, M., and Seppi, K. (2010). “Significance of MRI in diagnosis and differential diagnosis of Parkinson’s disease,” Neurodegener. Dis. 7(5): 300–18.
Marras, C., Lohmann, K., Lang, A., and Klein, C. (2012). “Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples,” Neurology 78(13): 1016–24.
Mehanna, R. and Jankovic, J. (2013a). “Movement disorders in cerebrovascular disease,” Lancet Neurol. 12(6): 597–608.
Mehanna, R. and Jankovic, J. (2013b). “Movement disorders in multiple sclerosis and other demyelinating diseases,” J. Neurol. Sci. 328(1–2): 1–8.
Morris, J. and Jankovic, J. (2012). Neurological Clinical Examination (London: Hodder Arnold).
Morris, J. G., Jankelowitz, S. K., Fung, V. S., Clouston, P. D., Hayes, M. W., and Grattan-Smith, P. (2002). “Athetosis I: historical considerations,” Mov. Disord. 17(6): 1278–80.
Nicoletti, G., Lodi, R., Condino, F., Tonon, C., Fera, F., Malucelli, E., et al. (2006). “Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson’s disease and progressive supranuclear palsy,” Brain 129(Pt. 10): 2679–87.
Nicoletti, G., Tonon, C., Lodi, R., Condino, F., Manners, D., Malucelli, E., et al. (2008). “Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson’s disease,” Mov. Disord. 23(16): 2370–6.
Nygaard, T. G. (1995). “Dopa-responsive dystonia,” Curr. Opin. Neurol. 8(4): 310–13.
Ozelius, L. J., Lubarr, N., and Bressman, S. B. (2011). “Milestones in dystonia,” Mov. Disord. 26(6): 1106–26.
Patel, N., Jankovic, J., and Hallett, M. (2013) “Sensory aspects of movement disorders,” Lancet Neurol. (in press).
Paviour, D. C., Thornton, J. S., Lees, A. J., and Jäger, H. R. (2007). “Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy,” Mov. Disord. 22(1): 68–74.
Pita Lobo, P., Quattrocchi, G., Jutras, M. F., Sangla, S., Apartis, E., Vidailhet, M., et al. (2013), “Primary writing tremor and writer’s cramp: Two faces of a same coin?,” Mov. Disord. 28(9): 1306–7.
Schneider, S. A., Dusek, P., Hardy, J., Westenberger, A., Jankovic, J., Bhatia, K. (2013). “Genetics and pathophysiology of neurodegeneration with brain iron accumulation (NBIA),” Curr. Neuropharmacol. 11: 59–79.
Seppi, K. and Schocke, M. F. (2005). “An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism,” Curr. Opin. Neurol. 18(4): 370–5.
Seppi, K., Schocke, M. F., Esterhammer, R., Kremser, C., Brenneis, C., Mueller, J., et al. (2003). “Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy,” Neurology 60(6): 922–7.
Sitburana, O., Wu, L. J., Sheffield, J. K., Davidson, A., and Jankovic, J. (2009). “Motor overflow and mirror dystonia,” Parkinsonism Relat. Disord. 15: 758–61.
Stebbins, G. T., Goetz, C. G., Burn, D. J., Jankovic, J., Khoo, T. K., and Tilley, B. C. (2013). “How to identify tremor dominant and postural instability/gait difficulty groups with the Movement Disorder Society Unified Parkinson’s Disease Rating Scale: Comparison with the Unified Parkinson’s Disease Rating Scale,” Mov. Disord. (in press).
Stern, M. B., Lang, A., and Poewe, W. (2012). “Toward a redefinition of Parkinson’s disease,” Mov. Disord. 27(1): 54–60.
van Gaalen, J., Giunti, P., and van de Warrenburg, B. P. (2011). “Movement disorders in spinocerebellar ataxias,” Mov. Disord. 26(5): 792–800.
Walker, R. H. (2011). “Differential diagnosis of chorea,” Curr. Neurol. Neurosci. Rep. 11(4): 385–95.
Waln, O. and Jankovic, J. (2013). “An update on tardive dyskinesia. Tremor and Other Hyperkinetic Disorders,” Tremor & Other Hyperkinet. Mov. 3, .
Williams, E. R., Jones, R. E., Baker, S. N., Baker, M. R. (2010). “Slow orthostatic tremor can persist when walking backward,” Mov. Disord. 25(6): 795–7.
Yaltho, T. C. and Jankovic, J. (2011). “The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms,” Mov. Disord. 26(9): 1582–92.
Zinner, S. H. and Mink, J. W. (2010). “Movement disorders I: tics and stereotypies,” Pediatr. Rev. 31(6): 223–33.